Clinical Data:

• No specific clinical data supporting the product's use for weight loss through intermittent fasting, but the underlying principles have a strong evidence base in weight management and behavior modification.
• Broader evidence suggests the effectiveness of intermittent fasting in promoting weight loss and improving metabolic health, which may be applicable to individuals using DoFasting for weight management purposes.

Mechanism:

• DoFasting utilizes intermittent fasting as a method for weight loss and provides personalized plans based on individual preferences and needs.

Safety and Side Effects:

• No reported side effects.

Patient Eligibility:

• Suitable for individuals aged 18 and above who are willing to engage in intermittent fasting and exercise.

Cost:

• 1-month plan: $8.42/week
• 3-month plan: $3.64/week
• 6-month plan: $2.62/week